cisapride has been researched along with Neoplasms in 1 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cisapride is a strong prokinetic gastrointestinal drug that could have a role in the prevention of DE." | 6.70 | Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration. ( Caristi, N; Maisano, R; Pergolizzi, S; Salimbeni, V; Spadaro, P; Toscano, G, 2001) |
| "Cisapride is a strong prokinetic gastrointestinal drug that could have a role in the prevention of DE." | 2.70 | Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration. ( Caristi, N; Maisano, R; Pergolizzi, S; Salimbeni, V; Spadaro, P; Toscano, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maisano, R | 1 |
| Spadaro, P | 1 |
| Toscano, G | 1 |
| Caristi, N | 1 |
| Pergolizzi, S | 1 |
| Salimbeni, V | 1 |
1 trial available for cisapride and Neoplasms
| Article | Year |
|---|---|
Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisapride; Cisplatin; Dexamet | 2001 |